Please download the dossier by clicking on the dossier button x
×

THERAPEUTIC APPLICATION OF ISOLATED NATURALLY-OCCURRING SOLUBLE TRUNCATED FORMS OF IL-23 RECEPTOR

  • US 20130183755A1
  • Filed: 01/23/2013
  • Published: 07/18/2013
  • Est. Priority Date: 03/31/2010
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of inhibiting IL-23R-mediated cell signaling in a mammalian cell, comprising the steps of:

  • a) providing a mammalian cell in need thereof;

    b) providing a recombinant IL-23Rα

    protein, said recombinant IL-23Rα

    protein has an amino acid sequence selected from the group consisting of SEQ ID NO;

    2 and SEQ ID NO;

    4; and

    c) exposing said mammalian cell to an effective amount of said recombinant IL-23Rα

    protein, thereby inhibits IL-23R mediated cell signaling in said mammalian cell.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×